Sempra
SRE NYSE Multi-Utilities Financials FY2016βFY2025
Sempra's revenue rose 3.9% to $13.7 billion in fiscal 2025. Its net margin was 13.4%, down from 21.7% a year earlier. Free cash flow was β$6.0 billion. It paid out $1.7 billion in dividends and buybacks. The diluted share count rose 2.5%.
About these figures. Share counts and per-share figures for earlier years are restated for a stock split (2-for-1), so every year is on today's share basis.
What Sempra does
No business description yet.
- Legal name
- SEMPRA
- Fiscal year ends
- December 31, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0001032208-26-000010
0001032208
Revenue and margins
Sempra had $13.7B of revenue in fiscal 2025, up 3.9% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 0.1% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β$6.0B in fiscal 2025, β44.1% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Sempra returned $1.7B to shareholders in fiscal 2025. The diluted share count rose 2.5%.
Value Sempra yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β$35.0B and divides by 653.8M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 28.5x Β· peers 20.5x Β· sector 20.4x.
Balance sheet
Cash, debt and the ratios that show how comfortably Sempra can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $559M | $370M | $236M | $1.6B | $29.0M |
| Debt incl. finance leases | $24.6B | $28.9B | $31.1B | $35.8B | $35.0B |
| Net debt / EBITDA | 6.2x | 5.6x | 4.5x | 5.5x | 6.0x |
| Debt / equity | 1.0x | 1.1x | 1.1x | 1.2x | 1.1x |
| Interest coverage | 1.7x | 2.9x | 3.5x | 3.6x | 2.2x |
| Current ratio | 0.4x | 0.6x | 0.5x | 0.6x | 1.6x |
| Quick ratio | 0.4x | 0.6x | 0.5x | 0.5x | 1.6x |
| Total assets | $72.0B | $78.6B | $87.2B | $96.2B | $110.9B |
| Total liabilities | $44.6B | $49.3B | $53.5B | $58.4B | $72.1B |
| Shareholders' equity | $26.0B | $27.1B | $28.7B | $31.2B | $31.6B |
| Net debt (β = net cash) | $24.1B | $28.5B | $30.8B | $34.3B | $35.0B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.6M
3 insiders
Sold, 12 months
$7.4M
7 insiders
Of sales under plans
87%
$6.4M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Jun 17, 2026 | Caroline Ann WinnExecutive Vice President | Sold | 8,000 | $90.55 | $0.7M | Form 4 |
| May 18, 2026 | Pablo FerreroDirector | Sold | 2,600 | $89.53 | $0.2M | Form 4 |
| May 14, 2026 | Diana L DayChief Legal Counsel | Sold plan | 3,300 | $92.13 | $0.3M | Form 4 |
| Apr 1, 2026 | Justin Christopher BirdExecutive Vice President | Sold plan | 1,128 | $96.69 | $0.1M | Form 4 |
| Mar 16, 2026 | Dyan Z. WoldVP, Controller and CAO | Sold plan | 1,539 | $95.38 | $0.1M | Form 4 |
| Mar 12, 2026 | Jennifer M KirkDirector | Bought | 1,000 | $93.44 | $0.1M | Form 4 |
| Mar 11, 2026 | Cynthia J WarnerDirector | Bought | 2,500 | $92.95 | $0.2M | Form 4 |
| Mar 11, 2026 | Richard J MarkDirector | Bought | 2,692 | $93.30 | $0.3M | Form 4 |
| Mar 9, 2026 | Karen L SedgwickExecutive VP and CFO | Sold plan | 4,872 | $92.58 | $0.5M | Form 4 |
| Jan 5, 2026 | Jeffrey W MartinChairman, CEO and President, Director | Sold plan | 23,111 | $87.21 | $2.0M | Form 4 |
| Jan 2, 2026 | Jeffrey W MartinChairman, CEO and President, Director | Sold plan | 30,000 | $89.29 | $2.7M | Form 4 |
| Nov 24, 2025 | Karen L SedgwickExecutive VP and CFO | Sold plan | 7,564 | $92.29 | $0.7M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 7 / 8 | 4 / 8 | 5 / 8 |
| Accruals ratio | β3.8% | β2.2% | β2.6% |
| Altman Z'' | 1.25 | 1.22 | 2.03 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Sempra SRE | $55.1B | 3.9% | β | β44.1% | 2.8% | 28.5x | 5 | |
| Xcel Energy XEL | $48.9B | 9.1% | 17.6% | β46.5% | 4.9% | 21.4x | 4 | Compare β |
| DTE Energy DTE | $27.4B | 27.0% | 15.0% | β | 6.1% | 21.7x | 6 | Compare β |
| Dominion Energy D | $57.4B | 14.2% | 26.7% | β44.2% | 4.9% | 19.3x | 6 | Compare β |
| Consolidated Edison ED | $42.2B | 10.9% | 17.4% | 0.2% | 4.7% | 19.5x | 6 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $10.2B | $9.6B | $10.1B | $10.8B | $11.4B | $12.9B | $14.4B | $16.7B | $13.2B | $13.7B |
| Interest expense | $553M | $622M | $886M | $1.1B | $1.1B | $1.2B | $1.1B | $1.3B | $1.0B | $1.5B |
| Pretax income | $1.8B | $1.3B | $478M | $1.8B | $1.8B | $833M | $2.0B | $3.3B | $2.7B | $1.8B |
| Income tax | $389M | $938M | β$49.0M | $315M | $249M | $99.0M | $556M | $490M | $219M | $701M |
| Net income | $1.4B | $256M | $1.1B | $2.4B | $4.1B | $1.3B | $2.1B | $3.1B | $2.9B | $1.8B |
| Diluted EPS | $2.73 | $0.51 | $1.71 | $3.65 | $6.44 | $2.01 | $3.31 | $4.79 | $4.42 | $2.75 |
| Diluted shares | 0.50B | 0.50B | 0.54B | 0.56B | 0.58B | 0.63B | 0.63B | 0.63B | 0.64B | 0.65B |
| Cash flow | ||||||||||
| Cash from operations | $2.3B | $3.6B | $3.5B | $3.1B | $2.6B | $3.8B | $1.1B | $6.2B | $4.9B | $4.6B |
| Capital expenditure | $4.2B | $3.7B | $3.5B | $3.7B | $4.7B | $5.0B | $5.4B | $8.4B | $8.2B | $10.6B |
| Free cash flow | β$1.9B | β$80.0M | β$28.0M | β$620M | β$2.1B | β$1.2B | β$4.2B | β$2.2B | β$3.3B | β$6.0B |
| Depreciation and amortization | $1.3B | $1.4B | $1.5B | $1.6B | $1.7B | $1.9B | $2.0B | $2.2B | $2.4B | $2.6B |
| Stock-based compensation | $52.0M | $82.0M | $83.0M | $75.0M | $71.0M | $63.0M | $71.0M | $80.0M | $86.0M | $64.0M |
| Acquisitions | $1.3B | $147M | $9.6B | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Share buybacks | $56.0M | $15.0M | $21.0M | $26.0M | $566M | $339M | $478M | $32.0M | $43.0M | $58.0M |
| Dividends paid | $686M | $755M | $877M | $993M | $1.2B | $1.3B | $1.4B | $1.5B | $1.5B | $1.6B |
| Dividends and buybacks | $742M | $770M | $898M | $1.0B | $1.7B | $1.7B | $1.9B | $1.5B | $1.5B | $1.7B |
| Balance sheet | ||||||||||
| Cash and short-term investments | $349M | $288M | $102M | $108M | $960M | $559M | $370M | $236M | $1.6B | $29.0M |
| Total debt | $17.1B | $19.4B | $24.6B | $25.8B | $24.2B | $24.6B | $28.9B | $31.1B | $35.8B | $35.0B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $1.3B | $1.3B | $1.3B | $1.3B | $1.3B | $1.3B | $1.3B |
| Current assets | $3.1B | $3.3B | $3.6B | $3.3B | $4.5B | $4.4B | $5.9B | $5.5B | $5.3B | $34.8B |
| Current liabilities | $5.9B | $6.6B | $7.5B | $9.2B | $6.8B | $10.0B | $9.9B | $10.1B | $9.7B | $21.9B |
| Inventory | $258M | $307M | $258M | $277M | $308M | $389M | $403M | $482M | $559M | $561M |
| Property and equipment, net | $32.9B | $36.5B | $34.4B | $36.5B | $40.0B | $43.9B | $47.8B | $55.0B | $61.4B | $49.0B |
| Total assets | $47.8B | $50.5B | $60.6B | $65.7B | $66.6B | $72.0B | $78.6B | $87.2B | $96.2B | $110.9B |
| Total liabilities | $32.5B | $35.3B | $41.4B | $43.9B | $41.7B | $44.6B | $49.3B | $53.5B | $58.4B | $72.1B |
| Shareholders' equity | $13.0B | $12.7B | $17.1B | $19.9B | $23.4B | $26.0B | $27.1B | $28.7B | $31.2B | $31.6B |
| Margins | ||||||||||
| EBITDA margin | 36.3% | 34.7% | 28.3% | 40.7% | 39.8% | 30.2% | 35.2% | 40.7% | 47.0% | 42.9% |
| Net margin | 13.5% | 2.7% | 11.2% | 21.8% | 36.1% | 10.3% | 14.8% | 18.4% | 21.7% | 13.4% |
| FCF margin | β18.7% | β0.8% | β0.3% | β5.7% | β18.3% | β9.1% | β29.2% | β13.0% | β25.1% | β44.1% |
| Returns | ||||||||||
| Return on capital | 6.4% | 2.9% | 3.5% | 5.1% | 5.2% | 3.6% | 4.1% | 6.4% | 5.1% | 2.8% |
| Return on capital employed | 6.1% | 4.4% | 2.8% | 5.2% | 4.9% | 3.3% | 4.7% | 6.3% | 4.6% | 3.8% |
| Return on equity | 11.1% | 2.0% | 7.6% | 12.7% | 19.0% | 5.3% | 8.1% | 11.0% | 9.6% | 5.9% |
| Return on assets | 3.1% | 0.5% | 2.0% | 3.7% | 6.2% | 1.9% | 2.8% | 3.7% | 3.1% | 1.8% |
| Growth | ||||||||||
| Revenue growth | β0.5% | β5.3% | 4.8% | 7.2% | 5.0% | 13.1% | 12.3% | 15.8% | β21.1% | 3.9% |
| Net income growth | 1.6% | β81.3% | 339.8% | 109.8% | 73.8% | β67.9% | 62.3% | 43.8% | β6.9% | β35.8% |
| EPS growth | 1.7% | β81.5% | 238.6% | 113.2% | 76.7% | β68.8% | 64.7% | 44.7% | β7.7% | β37.8% |
| Share count change | 0.1% | 0.5% | 7.0% | 4.5% | 3.6% | 7.1% | 1.1% | 0.0% | 0.8% | 2.5% |
| Financial health | ||||||||||
| Net debt / EBITDA | 4.5x | 5.7x | 8.6x | 5.8x | 5.1x | 6.2x | 5.6x | 4.5x | 5.5x | 6.0x |
| Debt / equity | 1.3x | 1.5x | 1.4x | 1.3x | 1.0x | 1.0x | 1.1x | 1.1x | 1.2x | 1.1x |
| Interest coverage | 4.3x | 3.1x | 1.5x | 2.6x | 2.7x | 1.7x | 2.9x | 3.5x | 3.6x | 2.2x |
| Current ratio | 0.5x | 0.5x | 0.5x | 0.4x | 0.7x | 0.4x | 0.6x | 0.5x | 0.6x | 1.6x |
| Quick ratio | 0.5x | 0.5x | 0.5x | 0.3x | 0.6x | 0.4x | 0.6x | 0.5x | 0.5x | 1.6x |
| Capital allocation | ||||||||||
| Capex / revenue | 41.4% | 38.4% | 35.1% | 34.2% | 41.1% | 39.0% | 37.1% | 50.2% | 62.3% | 77.5% |
| Stock comp / revenue | 0.5% | 0.9% | 0.8% | 0.7% | 0.6% | 0.5% | 0.5% | 0.5% | 0.7% | 0.5% |
| Quality scores | ||||||||||
| Piotroski F-score | 3.0 | 3.0 | 4.0 | 5.0 | 5.0 | 5.0 | 5.0 | 7.0 | 4.0 | 5.0 |
| Altman Z'' | 1.2 | 0.9 | 0.8 | 0.8 | 1.4 | 0.9 | 1.1 | 1.3 | 1.2 | 2.0 |
| Accruals ratio | β2.1% | β6.9% | β4.3% | β1.2% | 2.3% | β3.6% | 1.3% | β3.8% | β2.2% | β2.6% |
Source: SEC EDGAR XBRL filings (CIK 0001032208). Data updated October 9, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.